Two Sigma Investments Portfolio holdings
AUM
$55.5B
1-Year Return
27.18%
This Quarter Return
-3.01%
1 Year Return
+27.18%
3 Year Return
+82.36%
5 Year Return
+135.75%
10 Year Return
+365.6%
AUM
$46B
AUM Growth
+$2.51B
(+5.8%)
Cap. Flow
+$2.44B
Cap. Flow
% of AUM
5.32%
Top 10 Holdings %
Top 10 Hldgs %
8.28%
Holding
3,576
New
447
Increased
1,213
Reduced
1,297
Closed
440
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$485M |
| 2 |
Broadcom
AVGO
|
+$251M |
| 3 |
Palantir
PLTR
|
+$233M |
| 4 |
Advanced Micro Devices
AMD
|
+$231M |
| 5 |
Salesforce
CRM
|
+$227M |
Top Sells
| 1 |
Progressive
PGR
|
+$264M |
| 2 |
Eli Lilly
LLY
|
+$254M |
| 3 |
Visa
V
|
+$246M |
| 4 |
Elevance Health
ELV
|
+$206M |
| 5 |
Intel
INTC
|
+$187M |
Sector Composition
| 1 | Technology | 18.19% |
| 2 | Healthcare | 13.46% |
| 3 | Financials | 10.58% |
| 4 | Industrials | 9.94% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Glimpse Group
VRAR
$31M
| $57.4K | ﹤0.01% |
+49,461
| New | +$57.4K |
|
|
BIOA
2902
BioAge Labs, Inc. Common Stock
BIOA
$176M
| $56.9K | ﹤0.01% |
+15,145
| New | +$56.9K |
|
2903
Big 5 Sporting Goods
BGFV
$32.5M
| $56.6K | ﹤0.01% |
58,569
-75,290
| -56% | -$72.8K |
|
2904
Werewolf Therapeutics
HOWL
$65.4M
| $56.5K | ﹤0.01% |
58,132
-35,308
| -38% | -$34.3K |
|
2905
Alto Neuroscience
ANRO
$106M
| $56.5K | ﹤0.01% |
26,142
-4,558
| -15% | -$9.85K |
|
|
BPT
2906
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $55.6K | ﹤0.01% |
100,497
-502
| -0.5% | -$278 |
|
2907
Quince Therapeutics
QNCX
$84.9M
| $54.7K | ﹤0.01% |
41,150
+10,809
| +36% | +$14.4K |
|
2908
Getty Images
GETY
$813M
| $54.7K | ﹤0.01% |
+31,599
| New | +$54.7K |
|
2909
Immuneering
IMRX
$341M
| $54.4K | ﹤0.01% |
35,757
-14,800
| -29% | -$22.5K |
|
2910
iBio
IBIO
$18.9M
| $54.2K | ﹤0.01% |
+13,484
| New | +$54.2K |
|
2911
Richtech Robotics
RR
$518M
| $53.2K | ﹤0.01% |
26,886
-15,117
| -36% | -$29.9K |
|
|
SQNS
2912
Sequans Communications
SQNS
$140M
| $52.5K | ﹤0.01% |
24,990
-33,811
| -58% | -$71K |
|
2913
SELLAS Life Sciences
SLS
$199M
| $52.2K | ﹤0.01% |
+48,287
| New | +$52.2K |
|
|
BCG
2914
Binah Capital Group
BCG
$29.9M
| $51.9K | ﹤0.01% |
26,871
| – | – |
|
2915
Real Brokerage
REAX
$1.07B
| $51.5K | ﹤0.01% |
12,696
-27,930
| -69% | -$113K |
|
|
ELEV
2916
DELISTED
Elevation Oncology
ELEV
| $50.3K | ﹤0.01% |
194,016
-21,934
| -10% | -$5.68K |
|
2917
CEL-SCI Corp
CVM
$67.7M
| $50.1K | ﹤0.01% |
7,247
+4,527
| +166% | +$31.3K |
|
2918
GrafTech
EAF
$254M
| $48.7K | ﹤0.01% |
5,567
+4,534
| +439% | +$39.6K |
|
2919
Air Industries Group
AIRI
$15.6M
| $48.3K | ﹤0.01% |
13,878
-4,382
| -24% | -$15.2K |
|
2920
BRC Inc
BRCC
$189M
| $48.3K | ﹤0.01% |
23,090
-37,574
| -62% | -$78.5K |
|
2921
GEE Group
JOB
$20.8M
| $47.5K | ﹤0.01% |
+235,085
| New | +$47.5K |
|
|
KRON
2922
DELISTED
Kronos Bio
KRON
| $46.1K | ﹤0.01% |
55,935
-7,326
| -12% | -$6.04K |
|
2923
Relmada Therapeutics
RLMD
$50.5M
| $46K | ﹤0.01% |
170,544
+42,965
| +34% | +$11.6K |
|
|
INTZ
2924
Intrusion
INTZ
$33M
| $44.8K | ﹤0.01% |
+39,999
| New | +$44.8K |
|
2925
Navitas Semiconductor
NVTS
$1.3B
| $44.8K | ﹤0.01% |
+21,850
| New | +$44.8K |
|